In contrast, 22% of the cells transduced with both the TCR and CD8 showed IFN-γ production against the tumor cell line encoding HPV16E7wt and 40% against the tumor cell line encoding the improved HLA-A2 binding epitope HPV16E7V. The gene discussed is CD8A; the disease is neoplasm.